ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
AKR7A2 | Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CRYZ | Crystallin, zeta (quinone reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ETHE1 | Ethylmalonic encephalopathy 1 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GCDH | Glutaryl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
HSD17B4 | Hydroxysteroid (17-beta) dehydrogenase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
IDH3A | Isocitrate dehydrogenase 3 (NAD+) alpha | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
IVD | Isovaleryl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
LDHB | Lactate dehydrogenase B | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MAOA | Monoamine oxidase A | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
MDH2 | Malate dehydrogenase 2, NAD (mitochondrial) | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
NSDHL | NAD(P) dependent steroid dehydrogenase-like | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
NXN | Nucleoredoxin | Enzymes Predicted intracellular proteins
| | | | | Mixed |
P4HA2 | Prolyl 4-hydroxylase, alpha polypeptide II | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
PDHB | Pyruvate dehydrogenase (lipoamide) beta | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PHGDH | Phosphoglycerate dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
PNPO | Pyridoxamine 5'-phosphate oxidase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PRDX1 | Peroxiredoxin 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PRDX5 | Peroxiredoxin 5 | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PRDX6 | Peroxiredoxin 6 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SOD1 | Superoxide dismutase 1, soluble | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
UGDH | UDP-glucose 6-dehydrogenase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
UQCRFS1 | Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |